Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-029092
Filing Date
2010-05-24
Accepted
2010-05-24 19:44:15
Documents
1
Period of Report
2010-05-24

Document Format Files

Seq Description Document Type Size
1 MAY 24 OPEN MARKET PURCHASE rrd276929.html 4  
1 MAY 24 OPEN MARKET PURCHASE rrd276929.xml 4 2967
  Complete submission text file 0001181431-10-029092.txt   5023
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8540 COLONNADE CENTER DRIVE SUITE 501 RALEIGH NC 27615
Business Address
FRANCO RICHARD A (Reporting) CIK: 0001212673 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 10855329